Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501).
- Citation:
- Ann Surg Oncol vol 31 (10) 7033-42
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; UG1CA189850, UG1CA233290, UG1CA233329, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Rebecca A Snyder Tyler J Zemla Qian Shi Diana Segovia Syed A Ahmad Eileen M O'Reilly Joseph M Herman Matthew H G Katz
- Networks:
- LAPS-NY016, LAPS-TX035, NORTHWELL, OH070
- Study
- Alliance-A021501
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: